Exelon (NASDAQ:EXC) Rating Lowered to Sell at StockNews.com

Posted by on Aug 9th, 2023

Exelon (NASDAQ:EXC – Get Free Report) was downgraded by research analysts at StockNews.com from a “hold” rating to a “sell” rating in a research note issued on Sunday.

Other analysts also recently issued reports about the company. Guggenheim upgraded Exelon from a “neutral” rating to a “buy” rating and set a $44.00 price target for the company in a report on Friday, July 7th. JPMorgan Chase & Co. dropped their price target on shares of Exelon from $50.00 to $46.00 in a research note on Wednesday, June 7th. Mizuho reduced their target price on shares of Exelon from $46.00 to $45.00 in a report on Tuesday, May 16th. BMO Capital Markets cut their price target on shares of Exelon from $46.00 to $44.00 in a report on Thursday, May 25th. Finally, Morgan Stanley reaffirmed an “overweight” rating and issued a $47.00 target price on shares of Exelon in a research report on Friday, July 21st. Two research analysts have rated the stock with a sell rating, one has issued a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat, Exelon has a consensus rating of “Hold” and an average target price of $44.50.

View Our Latest Stock Report on Exelon

Exelon Stock Up 0.3 %

Exelon stock opened at $40.08 on Friday. The company has a market capitalization of $39.89 billion, a P/E ratio of 18.91, a P/E/G ratio of 2.69 and a beta of 0.62. Exelon has a 1-year low of $35.19 and a 1-year high of $47.23. The company has a current ratio of 0.95, a quick ratio of 0.86 and a debt-to-equity ratio of 1.59. The firm’s fifty day simple moving average is $41.15 and its 200-day simple moving average is $41.53.

Exelon (NASDAQ:EXC – Get Free Report) last issued its earnings results on Wednesday, August 2nd. The company reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.40 by $0.01. Exelon had a net margin of 10.66% and a return on equity of 9.20%. The business had revenue of $4.82 billion for the quarter, compared to analyst estimates of $4.22 billion. During the same period in the previous year, the business earned $0.44 EPS. The firm’s revenue was up 13.7% on a year-over-year basis. Sell-side analysts forecast that Exelon will post 2.35 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Exelon

Several large investors have recently modified their holdings of EXC. Wealthfront Advisers LLC grew its position in Exelon by 3.1% during the first quarter. Wealthfront Advisers LLC now owns 43,752 shares of the company’s stock valued at $1,833,000 after acquiring an additional 1,322 shares during the period. Penserra Capital Management LLC acquired a new stake in shares of Exelon during the 4th quarter valued at $3,346,000. Gladstone Institutional Advisory LLC lifted its holdings in shares of Exelon by 6.6% in the fourth quarter. Gladstone Institutional Advisory LLC now owns 6,432 shares of the company’s stock valued at $278,000 after purchasing an additional 400 shares in the last quarter. Argent Trust Co purchased a new stake in shares of Exelon during the fourth quarter worth $228,000. Finally, Clarius Group LLC increased its position in Exelon by 4.8% during the first quarter. Clarius Group LLC now owns 8,901 shares of the company’s stock worth $373,000 after buying an additional 409 shares during the last quarter. Hedge funds and other institutional investors own 80.52% of the company’s stock.

About Exelon

(Get Free Report)

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.

Featured Stories

Analyst Recommendations for Exelon (NASDAQ:EXC)

Receive News & Ratings for Exelon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exelon and related companies with MarketBeat.com's FREE daily email newsletter.